Thus, the observed correlation between FSH and NAFLD in our study not only provides additional evidence but also contributes to the emerging understanding of the novel role of FSH in metabolic disorders. This evidence concerns the gene BRD2 and metabolic dysfunction-associated steatotic liver disease.